3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Lymphoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Meningioma
1
Melanoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Interventions
Doxorubicin
3
pembrolizumab
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
selinexor
1
ribociclib
1
peposertib
1
pazopanib
1
palbociclib
1
mirdametinib
1
liposomal doxorubicin
1
abemaciclib
1
X-Rays
1
Surgical Procedures, Operative
1
Radiotherapy
1
Radiation
1
Proton Therapy
1
Neoadjuvant Therapy
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Everolimus
1
Biopsy
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
HhAntag691
×
30 days
×
Clear all
No trials found.